Literature DB >> 17502535

Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.

Consuelo Huerta1, Saga Johansson, Mari-Ann Wallander, Luis A García Rodríguez.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) manifesting as deep vein thrombosis (DVT) and pulmonary embolism (PE) remains a common vascular disease with high mortality and morbidity. Our aim was to study the clinical spectrum of VTE, assess its incidence in the general population, and evaluate potential risk factors.
METHODS: Prospective cohort study with nested case-control analysis using the General Practice Research Database (1994-2000). Venous thromboembolism was newly diagnosed in 6550 patients. Cases were compared with a random sample of 10,000 controls and frequency-matched by age, sex, and year.
RESULTS: The incidence rate of VTE was 74.5 per 100,000 person-years. Overweight, varicose veins, inflammatory bowel disease, cancer, and oral corticosteroid use were associated with a greater risk of VTE. Ischemic heart disease, heart failure, and cerebrovascular diseases were associated with an increased risk of PE but not with DVT. Venous thromboembolism was strongly associated with fractures (odds ratio [OR], 21.3; 95% confidence interval [CI], 15.7-28.9) and surgery (OR, 25.0; 95% CI, 14.4-43.5). In women, the risk of VTE was 1.9 (95% CI, 1.5-2.3) among those receiving opposed hormone therapy (in which the woman takes estrogen throughout the month and progesterone for 10-14 days later in the month) and 1.9 (95% CI, 1.4-2.5) among those taking oral contraceptives. Cancer and cerebrovascular diseases presented a greater relative risk of fatal PE compared with nonfatal PE.
CONCLUSIONS: Overweight, varicose veins, cancer, inflammatory bowel disease, fractures, surgery, and use of oral corticosteroids, oral contraceptives, and opposed hormone therapy were independent risk factors for both DVT and PE. The magnitude of the association with some risk factors varied between DVT and PE, as well as between fatal and nonfatal PE.

Entities:  

Mesh:

Year:  2007        PMID: 17502535     DOI: 10.1001/archinte.167.9.935

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  104 in total

1.  Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian
Journal:  Dig Dis Sci       Date:  2011-01-30       Impact factor: 3.199

2.  The D-Dimer test in combination with a decision rule for ruling out deep vein thrombosis in primary care: diagnostic technology update.

Authors:  Annette Plüddemann; Matthew Thompson; Christopher P Price; Jane Wolstenholme; Carl Heneghan
Journal:  Br J Gen Pract       Date:  2012-05       Impact factor: 5.386

3.  Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.

Authors:  Bikramjit Singh; Saurabh Kedia; Gauree Konijeti; Venigalla Pratap Mouli; Rajan Dhingra; Lalit Kurrey; Saurabh Srivastava; Rajesh Pradhan; Govind Makharia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2015-02-07

4.  Effect of early active range of motion rehabilitation on outcome measures after partial meniscectomy.

Authors:  Brent M Kelln; Christopher D Ingersoll; Susan Saliba; Mark D Miller; Jay Hertel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-03-12       Impact factor: 4.342

Review 5.  Quality of care delivered to hospitalized inflammatory bowel disease patients.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

6.  The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.

Authors:  J Antonio Aviña-Zubieta; Vidula M Bhole; Neda Amiri; Eric C Sayre; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-09-29       Impact factor: 19.103

7.  Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.

Authors:  Elizabeth A Scoville; Gauree G Konijeti; Deanna D Nguyen; Jenny Sauk; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

Review 8.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 9.  Venous thromboembolism in cirrhosis: a review of the literature.

Authors:  Michelle Buresi; Russell Hull; Carla S Coffin
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

10.  Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.

Authors:  Hussain R Yusuf; W Craig Hooper; Michele G Beckman; Qing C Zhang; James Tsai; Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.